News

Filter

1 to 9 of 96307 results

Health Canada issues import ban from three Indian drug plants

Health Canada issues import ban from three Indian drug plants

01-10-2014

Regulator Health Canada has taken action to stop the imports from three Indian manufacturing sites.

Apotex Research Private LimitedCanadaIndiaIpca LaboratoriesPharmaceuticalRegulation

Boehringer Ingelheim invests 100 million euros to expanded Respimat production

01-10-2014

German family-owned pharma major Boehringer Ingelheim is investing more than 100 million euros ($127…

Boehringer IngelheimGermanyMarkets & MarketingPharmaceuticalProductionRespimatRespiratory and PulmonarySpiriva RespimatUK

EC guideline on facilitating applications for pediatric investigation plans

01-10-2014

The European Commission has published a revised guideline on applications for pediatric investigation…

EuropePharmaceuticalResearch

FDA grants to stimulate drug and device development for rare diseases

01-10-2014

The US Food and Drug Administration yesterday announced it has awarded 15 grants totaling more than $19…

FinancialPharmaceuticalRare diseasesResearchUSA

Long-acting insulin is safer, more effective for patients with type 1 diabetes

01-10-2014

Long-acting insulin is safer and more effective than intermediate-acting insulin for patients with type…

DiabetesInsulin DetemirInsulin Glargine [rDNA origin] InjectionPharmaceuticalResearch

ESMO 2014: Boehringer Ingelheim’s new data for afatinib and Array’s binimetinib

ESMO 2014: Boehringer Ingelheim’s new data for afatinib and Array’s binimetinib

01-10-2014

German family-owned drug major Boehringer Ingelheim has presented new data at the annual congress of…

afatinibArray BioPharmabinimetinibBoehringer IngelheimGermanyOncologyPharmaceuticalResearch

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

Sanofi and Regeneron's dupilumab meets all primary and secondary endpoints Phase IIa study

01-10-2014

French drug major Sanofi and US biotech company Regeneron's dupilumab has met all primary and secondary…

dupilumabFrancePharmaceuticalRegeneronResearchRespiratory and PulmonarySanofiUSA

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

01-10-2014

Data posters presented at this year’s European Society for Medical Oncology (ESMO) Congress in Madrid,…

EisaiHalavenJapanOncologyPharmaceuticalResearchSpain

1 to 9 of 96307 results

Back to top